Texas 2009 - 81st Regular

Texas Senate Bill SB1886 Latest Draft

Bill / Engrossed Version Filed 02/01/2025

Download
.pdf .doc .html
                            By: Ellis S.B. No. 1886


 A BILL TO BE ENTITLED
 AN ACT
 relating to diagnostic testing of pregnant women and certain
 newborns.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1. The heading to Section 81.090, Health and Safety
 Code, is amended to read as follows:
 Sec. 81.090. DIAGNOSTIC [SEROLOGIC] TESTING DURING
 PREGNANCY AND AFTER BIRTH.
 SECTION 2. Section 81.090, Health and Safety Code, is
 amended by amending Subsections (a), (b), (c), (i), (j), (k), and
 (l) and adding Subsections (a-1), (c-1), and (c-2) to read as
 follows:
 (a) A physician or other person permitted by law to attend a
 pregnant woman during gestation or at delivery of an infant shall:
 (1) take or cause to be taken a sample of the woman's
 blood or other appropriate specimen at the first examination and
 visit;
 (2) submit the sample to an appropriately certified
 [a] laboratory [approved under this section] for diagnostic testing
 approved by the United States Food and Drug Administration for:
 (A) [a standard serologic test for] syphilis
 [approved by the board];
 (B) [a standard serologic test for] HIV infection
 [approved by the board]; and
 (C) [a standard serologic test for] hepatitis B
 infection [approved by the board]; and
 (3) retain a report of each case for nine months and
 deliver the report to any successor in the case.
 (a-1)  A physician or other person permitted by law to attend
 a pregnant woman during gestation or at delivery of an infant shall:
 (1)  take or cause to be taken a sample of the woman's
 blood or other appropriate specimen at an examination in the third
 trimester of the pregnancy;
 (2)  submit the sample to an appropriately certified
 laboratory for a diagnostic test approved by the United States Food
 and Drug Administration for HIV infection; and
 (3)  retain a report of each case for nine months and
 deliver the report to any successor in the case.
 (b) A successor is presumed to have complied with this
 section if the successor in good faith obtains a record that
 indicates compliance with Subsections (a) and (a-1), if applicable.
 (c) A physician or other person in attendance at a delivery
 shall:
 (1) take or cause to be taken a sample of blood or
 other appropriate specimen from the mother on admission for
 delivery; and
 (2) submit the sample to an appropriately certified
 [a] laboratory [approved under this section] for diagnostic testing
 approved by the United States Food and Drug Administration for:
 (A) [a standard serologic test for] syphilis
 [approved by the board]; and
 (B) [a standard serologic test for HIV infection
 approved by the board; and
 [(C) a standard serologic test for] hepatitis B
 infection [approved by the board].
 (c-1)  If the physician or other person in attendance at the
 delivery does not find in the woman's medical records results from
 the diagnostic test for HIV infection performed under Subsection
 (a-1), the physician or person shall:
 (1)  take or cause to be taken a sample of blood or
 other appropriate specimen from the mother;
 (2)  submit the sample to an appropriately certified
 laboratory for diagnostic testing approved by the United States
 Food and Drug Administration for HIV infection; and
 (3)  instruct the laboratory to expedite the processing
 of the test so that the results are received less than six hours
 after the time the sample is submitted.
 (c-2)  If the physician or other person in attendance at the
 delivery does not find in the woman's medical records results from a
 diagnostic test for HIV infection performed under Subsection (a-1),
 and the diagnostic test for HIV infection was not performed before
 delivery under Subsection (c-1), the physician or other person in
 attendance at delivery shall:
 (1)  take or cause to be taken a sample of blood or
 other appropriate specimen from the newborn child less than two
 hours after the time of birth;
 (2)  submit the sample to an appropriately certified
 laboratory for a diagnostic test approved by the United States Food
 and Drug Administration for HIV infection; and
 (3)  instruct the laboratory to expedite the processing
 of the test so that the results are received less than six hours
 after the time the sample is submitted.
 (i) Before conducting or causing to be conducted a
 diagnostic [standard serologic] test for HIV infection under this
 section, the physician or other person shall advise the woman that
 the result of a test taken under this section is confidential as
 provided by Subchapter F, but that the test is not anonymous. The
 physician or other person shall explain the difference between a
 confidential and an anonymous test to the woman and that an
 anonymous test may be available from another entity. The physician
 or other person shall make the information available in another
 language, if needed, and if resources permit. The information
 shall be provided by the physician or another person, as needed, in
 a manner and in terms understandable to a person who may be
 illiterate if resources permit.
 (j) The result of a [standard] test for HIV infection under
 Subsection (a)(2)(B), (a-1), (c-1), or (c-2) [(c)(2)(B)] is a test
 result for purposes of Subchapter F.
 (k) Before the [blood] sample is taken, the health care
 provider shall distribute to the patient printed materials about
 AIDS, HIV, hepatitis B, and syphilis. A health care provider shall
 verbally notify the patient that an HIV test shall be performed if
 the patient does not object. If the patient objects, the patient
 shall be referred to an anonymous testing facility or instructed
 about anonymous testing methods. The health care provider shall
 note on the medical records that the distribution of printed
 materials was made and that verbal notification was given. The
 materials shall be provided to the health care provider by the
 department [Texas Department of Health] and shall be prepared and
 designed to inform the patients about:
 (1) the incidence and mode of transmission of AIDS,
 HIV, hepatitis B, and syphilis;
 (2) how being infected with HIV, AIDS, hepatitis B, or
 syphilis could affect the health of their child;
 (3) the available cure for syphilis;
 (4) the available treatment to prevent
 maternal-infant HIV transmission; and
 (5) methods to prevent the transmission of the HIV
 virus, hepatitis B, and syphilis.
 (l) A physician or other person may not conduct a diagnostic
 [standard] test for HIV infection under Subsection (a)(2)(B),
 (a-1), or (c-1) [(c)(2)(B)] if the woman objects. A physician or
 other person may not conduct a diagnostic test for HIV infection
 under Subsection (c-2) if a parent, managing conservator, or
 guardian objects.
 SECTION 3. Subsections (d), (e), (f), and (h), Section
 81.090, Health and Safety Code, are repealed.
 SECTION 4. (a) Subsections (a), (c), (i), and (k), Section
 81.090, Health and Safety Code, as amended by this Act, apply only
 to a test performed on or after the effective date of this Act. A
 test performed before the effective date of this Act is covered by
 the law in effect immediately before the effective date of this Act,
 and the former law is continued in effect for that purpose.
 (b) Subsections (a-1), (c-1), and (c-2), Section 81.090,
 Health and Safety Code, as added by this Act, and Subsections (b),
 (j), and (l), Section 81.090, Health and Safety Code, as amended by
 this Act, apply only to a physician or other person attending a
 pregnant woman during gestation or at delivery of an infant on or
 after January 1, 2010.
 SECTION 5. This Act takes effect September 1, 2009.